top of page


NegotiumBio supports Pharmaceutical and Biotechnology innovators programs across all modalities - small and large molecule, cell and gene therapies. We have unique direct experience in leading engagement negotiations for outsourced manufacturing with CAR-T, TCR, viral vector, and CRISPR based therapies.  

Relevant transaction and negotiation experience includes – but is not limited – to the following:

Outsourced Manufacturing Protein Purification
Identification of novel manufacturing options to RFP assessments
  • NPV = $30+M

  • Market research, full assessment of capacities, budget and timelines

  • Enabled our client to engage with players beyond their classic circle of suppliers

  • Enabled some suppliers to engage with a new industry.

Contact us to discuss how we can help you meet your project deadlines and pricing goals.

bottom of page